September 2018 Vol 11, No 6

David B. Nash, MD, MBA

Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015

Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD

Stakeholder Perspective

The Importance and Benefits of Smoking-Cessation Therapy

Jack E. Fincham, PhD, RPh

Clinical, Original Research

Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia

Craig White, PhD; Winghan Jacqueline Kwong, PharmD, PhD; Hilary Armstrong, PhD; Michael Behling; Jeffrey Niemira; Kathy Lang, PhD

Stakeholder Perspective

Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage

F. Randy Vogenberg, PhD, RPh

Business, Original Research

Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies

Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh

Results 1 - 4 of 4